Potential replication of induced pluripotent stem cells for craniofacial reconstruction

Current Stem Cell Research and Therapy

Volumn 9, Issue 3, 2014, Pages 205-214

  Fu, Yao ^a   Deng, Shuwen ^a   Wang, Jing ^b   Chen, Zhaozhao ^a   Zhang, Shu ^a   Wu, Songtao ^a   Jiang, Yan ^a   Ye, Ling ^a   Peng, Qiang ^a   Lin, Yunfeng ^a  

^a SICHUAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell differentiation; Craniofacial reconstruction; Embryonic stem cells; Induced pluripotent stem cells; Regenerative medicine; Somatic cells

Indexed keywords

ADULT; CRANIOFACIAL ABNORMALITIES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84904470025     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666140213155800     Document Type: Review

References (98)

1. Akintoye SO, Lam T, Shi S, Brahim J, Collins MT, Robey PG. Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone 2006; 38(6): 758-68.
2. Gronthos S, Brahim J, Li W, et al. Stem cell properties of human dental pulp stem cells. J Dent Res 2002; 81(8): 531-5.
3. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000; 97(25): 13625-30.
4. Miura M, Gronthos S, Zhao M, et al. SHED: stem cells from human exfoliated deciduous teeth. ProcNatl Acad Sci USA 2003; 100(10): 5807-12.
5. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004; 364(9429): 149-55.
6. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-7.
7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
8. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5): 861-72.
9. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007; 1(1): 39-49.
10. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318(5858): 1917-20.
11. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26(1): 101-6.
12. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451(7175): 141-6.
13. Okita K, Ichisaka T, Yamanaka S. Generation of germline competent induced pluripotent stem cells. Nature 2007; 448(7151): 313-7.
14. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322(5903): 949-53.
15. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322(5903): 945-9.
16. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458(7239): 771-5.
17. Woltjen K, Michael IP, Mohseni P, et al. Piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458(7239): 766-70.
18. Li G, Chunxu Y, Guisheng L. Efficient p53 gene targeting by homologous recombination in rat-induced pluripotent stem cells. Cell Prolif 2013; 46(1): 1-9.
19. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Molec Cell Biol 2008; 9(9): 725-9.
20. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007; 25(10): 1177-81.
21. Rybak A, Fuchs H, Smirnova L, et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem cell commitment. Nat Cell Biol 2008; 10(8): 987-93.
22. Judson RL, Babiarz JE, Venere M, Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 2009; 27(5): 459-61.
23. Li W, Wei W, Zhu S, et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009; 4(1): 16-9.
24. Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8(4): 376-88.
25. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008; 2(6): 525-8.
26. Bilousova G, Jun du H, King KB, et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells 2011; 29(2): 206-16.
27. Li F, Bronson S, Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cellular Biochem 2010; 109(4): 643-52.
28. Li F, Niyibizi C. Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo. BMC Cell Biol 2012; 13: 35.
29. Quarto N, Leonard B, Li S, et al. Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient specific induced-pluripotent stem cells. Proc Natl Acad Sci USA 2012; 109(1): 215-20.
30. Quarto N, Li S, Renda A, Longaker MT. Exogenous activation of BMP-2 signaling overcomes TGFbeta-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient specific induced pluripotent stem cells. Stem Cells 2012; 30(12): 2709-19.
31. Ye JH, Xu YJ, Gao J, et al. Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs. Biomaterials 2011; 32(22): 5065-76.
32. Tashiro K, Inamura M, Kawabata K, et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 2009; 27(8): 1802-11.
33. Kao CL, Tai LK, Chiou SH, et al. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 2010; 19(2): 247-58.
34. Jin GZ, Kim TH, Kim JH, et al. Bone tissue engineering of induced pluripotent stem cells cultured with macrochanneled polymer scaffold. J Biomed Mater Res Part A 2013; 101(5): 1283-91.
35. Duan X, Tu Q, Zhang J, et al. Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. J Cellular Physiol 2011; 226(1): 150-7.
36. Levi B, Hyun JS, Montoro DT, et al. In vivo directed differentiation of pluripotent stem cells for skeletal regeneration. Proc Natl Acad Sci USA 2012; 109(50): 20379-84.
37. Hayashi T, Misawa H, Nakahara H, et al. Transplantation of osteogenically differentiated mouse iPS cells for bone repair. Cell Transplant 2012; 21(2-3): 591-600.
38. Wu JY, Chen CH, Yeh LY, Yeh ML, Ting CC, Wang YH. Low power laser irradiation promotes the proliferation and osteogenic differentiation of human periodontal ligament cells via cyclic adenosine monophosphate. Int JOral Sci 2013; 5(2): 85-91.
39. Deyle DR, Khan IF, Ren G, et al. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Molec Ther 2012; 20(1): 204-13.
40. Itoh M, Kiuru M, Cairo MS, Christiano AM. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA 2011; 108(21): 8797-802.
41. Medvedev SP, Grigor'Eva EV, Shevchenko AI, et al. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev 2011; 20(6): 1099-112.
42. Ahmed N, Taylor DW, Wunder J, Nagy A, Gross AE, Kandel RA. Passaged human chondrocytes accumulate extracellular matrix when induced by bovine chondrocytes. J Tissue Eng Regenerative Med 2010; 4(3): 233-41.
43. Wei Y, Zeng W, Wan R, et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cells Mater 2012; 23: 1-12.
44. Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454(7204): 646-50.
45. Kuboth S, Kramer J, Rohwedel J. Chondrogenic differentiation in vitro of murine two-factor induced pluripotent stem cells is comparable to murine embryonic stem cells. Cells Tissues Organs 2012; 196(6): 481-9.
46. Guzzo RM, Gibson J, Xu RH, Lee FY, Drissi H. Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. J Cellular Biochem 2013; 114(2): 480-90.
47. Koyama N, Miura M, Nakao K, et al. Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. Stem Cells Dev 2013; 22(1): 102-13.
48. Choi S, Cho TJ, Kwon SK, Lee G, Cho J. Chondrogenesis of periodontal ligament stem cells by transforming growth factor-beta3 and bone morphogenetic protein-6 in a normal healthy impacted third molar. Int JOral Sci 2013; 5(1): 7-13.
49. Teramura T, Onodera Y, Mihara T, Hosoi Y, Hamanishi C, Fukuda K. Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cellular Reprogramming 2010; 12(3): 249-61.
50. Yang HS, La WG, Bhang SH, et al. Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery. Tissue EngPart A 2011; 17(13-14): 1809-18.
51. Yang SL, Harnish E, Leeuw T, et al. Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis. Protein Cell 2012; 3(12): 934-42.
52. Yoshida Y, Yamanaka S. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 2010; 122(1): 80-7.
53. Diekman BO, Christoforou N, Willard VP, et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. ProcNatl Acad Sci USA 2012; 109(47): 19172-7.
54. Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28(1): 31-40.
55. Sakurai M, Hayashi R, Kageyama T, Yamato M, Nishida K. Induction of putative stratified epithelial progenitor cells in vitro from mouse-induced pluripotent stem cells. J Artif Organs 2011; 14(1): 58-66.
56. Yoshida S, Yasuda M, Miyashita H, et al. Generation of stratified squamous epithelial progenitor cells from mouse induced pluripotent stem cells. PloS One 2011; 6(12): e28856.
57. Ohta S, Imaizumi Y, Okada Y, et al. Generation of human melanocytes from induced pluripotent stem cells. PloS One 2011; 6(1): e16182.
58. Bilousova G, Chen J, Roop DR. Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage. J Investig Dermatol 2011; 131(4): 857-64.
59. Darabi R, Pan W, Bosnakovski D, Baik J, Kyba M, Perlingeiro RC. Functional myogenic engraftment from mouse iPS cells. Stem Cell Rev 2011; 7(4): 948-57.
60. Beck AJ, Vitale JM, Zhao Q, et al. Differential requirement for utrophin in the induced pluripotent stem cell correction of muscle versus fat in muscular dystrophy mice. PloS One 2011; 6(5): e20065.
61. Fukada S, Higuchi S, Segawa M, et al. Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp Cell Res 2004; 296(2): 245-55.
62. Mizuno Y, Chang H, Umeda K, et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 2010; 24(7): 2245-53.
63. Quattrocelli M, Palazzolo G, Floris G, et al. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs. J Pathol 2011; 223(5): 593-603.
64. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 301(5632): 487-92.
65. Taura D, Noguchi M, Sone M, et al. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett 2009; 583(6): 1029-33.
66. Huang PI, Chou YC, Chang YL, et al. Enhanced differentiation of three-gene-reprogrammed induced pluripotent stem cells into adipocytes via adenoviral-mediated PGC-1alpha overexpression. Int JMolec Sci 2011; 12(11): 7554-68.
67. Hu BY, Weick JP, Yu J, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. ProcNatl Acad Sci USA 2010; 107(9): 4335-40.
68. Karumbayaram S, Novitch BG, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009; 27(4): 806-11.
69. Drury-Stewart D, Song M, Mohamad O, Yu SP, Wei L. Small molecule promoted feeder free and adherent differentiation of functional neurons from human embryonic and induced pluripotent stem cells. J Stem Cells 2011; 6(1): 1-7.
70. Mak SK, Huang YA, Iranmanesh S, et al. Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int 2012; 2012: 140427.
71. Haque A, Yue XS, Motazedian A, Tagawa Y, Akaike T. Characterization and neural differentiation of mouse embryonic and induced pluripotent stem cells on cadherin-based substrata. Biomaterials 2012; 33(20): 5094-106.
72. Kuo YC, Lin CC. Accelerated nerve regeneration using induced pluripotent stem cells in chitin-chitosan-gelatin scaffolds with inverted colloidal crystal geometry. Colloids Surf B Biointerf 2013; 103: 595-600.
73. Kuo YC, Chang YH. Differentiation of induced pluripotent stem cells toward neurons in hydrogel biomaterials. Colloids Surf B Biointerf 2013; 102: 405-11.
74. Kuo YC, Chen CW. Inverted colloidal crystal scaffolds with induced pluripotent stem cells for nerve tissue engineering. Colloids Surfaces B Biointerf 2013; 102: 789-94.
75. Kuo YC, Wang CT. Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface. Colloids Surf B Biointerf 2012; 100: 9-15.
76. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321(5893): 1218-21.
77. Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457(7227): 277-80.
78. Nemati S, Hatami M, Kiani S, et al. Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev 2011; 20(3): 503-14.
79. Esfandiari F, Fathi A, Gourabi H, Kiani S, Nemati S, Baharvand H. Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev 2012; 21(17): 3233-43.
80. Ishizuka T, Goshima H, Ozawa A, Watanabe Y. beta1-adrenoceptor stimulation enhances the differentiation of mouse induced pluripotent stem cells into neural progenitor cells. Neurosci Lett 2012; 525(1): 60-5.
81. Wang A, Tang Z, Park IH, et al. Induced pluripotent stem cells for neural tissue engineering. Biomaterials 2011; 32(22): 5023-32.
82. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008; 105(15):5856-61.
83. Uemura T, Takamatsu K, Ikeda M, et al. Transplantation of induced pluripotent stem cell-derived neurospheres for peripheral nerve repair. Biochem Biophys Res Commun 2012; 419(1): 130-5.
84. Oki K, Tatarishvili J, Wood J, et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 2012; 30(6): 1120-33.
85. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408(6808): 92-6.
86. Narazaki G, Uosaki H, Teranishi M, et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008; 118(5): 498-506.
87. Feng Q, Lu SJ, Klimanskaya I, et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010; 28(4): 704-12.
88. Choi KD, Yu J, Smuga-Otto K, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009; 27(3): 559-67.
89. Taura D, Sone M, Homma K, et al. Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report. Arterioscler Thromb Vasc Biol 2009; 29(7): 1100-3.
90. Homma K, Sone M, Taura D, et al. Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells. Atherosclerosis 2010; 212(1): 42-7.
91. Bajpai VK, Mistriotis P, Loh YH, Daley GQ, Andreadis ST. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res 2012; 96(3): 391-400.
92. Lian Q, Zhang Y, Zhang J, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010; 121(9): 1113-23.
93. Park SW, Jun Koh Y, Jeon J, et al. Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 2010; 116(25): 5762-72.
94. Zhou C, Cai X, Grottkau BE, Lin Y. BMP4 promotes vascularization of human adipose stromal cells and endothelial cells in vitro and in vivo. Cell Prolif 2013; 46(6): 695-704.
95. Rufaihah AJ, Huang NF, Jame S, et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 2011; 31(11): e72-9.
96. Matsumura G, Ishihara Y, Miyagawa-Tomita S, et al. Evaluation of tissue-engineered vascular autografts. Tissue Eng 2006; 12(11): 3075-83.
97. Brennan MP, Dardik A, Hibino N, et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008; 248(3): 370-7.
98. Hibino N, Duncan DR, Nalbandian A, et al. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thoracic Cardiovasc Surg 2012; 143(3): 696-703.